FIBROLAMELLAR CARCINOMA
Clinical trials for FIBROLAMELLAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIBROLAMELLAR CARCINOMA trials appear
Sign up with your email to follow new studies for FIBROLAMELLAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough cancers: testing a powerful drug duo
Disease control OngoingThis study is testing a new combination of two drugs, cobolimab and dostarlimab, for children and young adults with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest and most effective dose and to see how well the body tolera…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Global quest to tame childhood liver cancer
Disease control OngoingThis large international trial aims to find the best combinations of chemotherapy drugs and surgery to treat children and young adults with liver cancer (hepatoblastoma or hepatocellular carcinoma). It tests different treatment plans based on how severe the cancer is, with the go…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC